Clinical Trial Update: PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases

View source ↗

Summary

A monoinstitutional retrospective report of 46 consecutive small cell lung cancer patients treated with the PEI REGIMEN, providing real-world experience of this…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• PEI REGIMEN

Snippet

Sponsor: Azienda USL Reggio Emilia - IRCCS | Conditions: Small Cell Lung Cancer | Status: COMPLETED